|Publication number||US3876771 A|
|Publication date||Apr 8, 1975|
|Filing date||Sep 4, 1973|
|Priority date||Sep 4, 1973|
|Also published as||CA1054058A, CA1054058A1, DE2441627A1, DE2441627B2, DE2441627C3|
|Publication number||US 3876771 A, US 3876771A, US-A-3876771, US3876771 A, US3876771A|
|Inventors||Wilhelm G Denner|
|Original Assignee||Hallister Inc|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (7), Referenced by (23), Classifications (17)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent Denner 1 Apr. 8, 1975  SKIN PROTECTIVE GEL CONTAINING 3,134,720 5/1964 Green et a1. 424/362 X POLYVINYL METHYLETHER 0 3.269.903 8/1966 Von Fieandt et al 424/81 3.485915 12/1969 Gerstein et a1. 424/81 MONOISOPROPYL ESTER OF POLYWNYL 3.632.547 1/1972 Kajioka, 424/80 x METHYLETHER MALE"? C D 3.710.779 1/1973 Bunnell et a1 424/80 x 75 Inventor: i G. a. Chicago 1". 3,749,773 7/1973 Nlnger et a]. 424/78 X  Assignee: Hallister Incorporated, Chicago. Ill. Primary E wm.ner stanly Friedman  Filed: Sept. 4, 1973 Assistant E.\'aminer--Vera C. Clarke Attorney, Agent, or Firm-Hofgren, Wegner, Allen, ] Appl 394361 Stellman & McCord  US. Cl. 424/78; 252/316; 424/80; 57 ABS-T A T 424/81; 424/362 1 e R  Int. Cl A61k 9/00 The Present mvemlo" Provides a Protective 5km coat-  Field of Search 424/78, s0. 81, 362; ing material in the form of gel primarily intended for 252 31 use in combination with ostomy appliances and the like. The gelatinous material is made up of a film- 5 References Cited forming protective colloidal materia] in combination UNITED STATES PATENTS with a solvent and a gelling agent.
2542897 2/1951 Brown et a1. 424/362 X 6 Claims, No Drawings SKIN PROTECTIVE GEL CONTAINING POLYVINYL METHYLETIIER OR MONOISOPROPYL ESTER OF I OLYVINYL METHYLETHER MALEIC ACID BACKGROUND OF'VTHE INVENTION Surgical correction of intestinal disorders is becoming a common practice. Where the colon is damaged or infected, a portion or even all of the large intestine may be removed (colostomy), and the new terminus of the intestinal tract is led out through an opening made in the abdominal wall to form a stoma. Where the disturbance is in the small intestine or extends into the small intestine, the same technique may be employed and the operation in this instance is called an ileostomy. In the case of a colostomy, the waste material discharged from the stoma is generally noncorrosive and appliances, often referred to as ostomy appliances, are employed to collect and retain the discharged waste material for subsequent disposal. In the case of an ileostomy, the material discharged may still be incompletely digested and the discharge may include a significant amount of gastric juices which are still active and will attack the skin of the patient if allowed to come in contact therewith. Again, ostomy appliances are worn by the patient to collect the waste discharged from the ileostomy stoma, but care must be taken to effect a proper seal around the stoma not only to prevent soiling of the clothes of the wearer and the escape of unpleasant odors, problems common to both colostomy and ileostomy patients, but also to prevent the still active gastric juices from coming in contact with and damaging the skin.
causes skin irritation even though there has been no contact with discharged waste material. Repeated applications of an adhesive device serves further to irritate the skin.
Attempts have been made in the past to remedy the situation described above by providing a skin coating material in the form of a liquid which may be applied to the skin by a sponge or other means. Because the liquid was extremely fluid, it was difficult to maintain the liquid in place until it had dried, and often the patient was required to lie on his back while applying the liquid and permitting the same to dry to form a protective coating. This provided a far from satisfactory solution.
BRIEF SUMMARY OF THE INVENTION In accordance with the present invention, there is provided a skin coating or skin protective material in the form of a gel. The gel is sufficiently stiff as to be able to support itself in position without running, even when applied to the skin surface surrounding the stoma while the patient is standing. The gel dries to a thin protective coating against which the adhesive or other sealing means of the ostomy appliance may be pressed, and the stress of subsequently removing the appliance is directed primarily against the coating material rather than directly against the skin.
DETAILED DESCRIPTION OF THE INVENTION As previously indicated, the gel of the present invention comprises film formers in a solvent mixed with pre- 7 servatives and a gelling agent. The preferred ingredients and their proportions are set forth below, and where available the trade name and manufacturer, as presently known, is also stated.
Chemical Name Isopropanol(70%) Methyl para-hydroxybenzoate Butyl para-hydroxybenzoate Polyvinyl pyrrolidone having a molecular wt.
Polyvinyl methylether having an acid value (I) and being soluble in Trade Name Manufacturer Shell or Exxon Tenneco Hayden Div.
Lutonal M-40 BASF Wyandotte water and low boiling alcohols Modified polyacrylic acid having a molecular wt.
Polyoxyethylene cocoamine having l5 oxy groups Monoisopropyl ester polyvinyl methylether/maleic acid 2,4 Hexadienoic acid Hydroxypropyl cellulose having a molecular wt.
As a consequence of the foregoing, ostomy appliances have been provided with an adhesive face adapted to adhere to the skin surrounding the stoma, and in some cases have used a gum karaya seal such as the seal shown and described in US Pat. No. 3,302,647. In all cases, a bag or other container is provided in conjunction with the sealing means in order to collect the discharged waste.
In the case of the ostomy appliance, which includes a ring-like member having an adhesive face on one side and a bag to receive the discharged material on the other. the application and removal of the device often Carbopol 934 B.F. Goodrich Ethomeen C/ZS Armour Chem.
Gantrez ES 335 GAF Sorbic acid Pfizer Chem Co. Klucel GF Hercules Inc.
Of the ingredients set forth above, the isopropanol is, of course, the solvent, Gantrez ES 335 I is a film former, as are polyvinyl pyrrolidone K-30 and the Lutonal M-40. The Carbopol 934 and the Klucel GF are the gelling agents, while the parasepts are the preservatives and the Ethomeen C/25 is neutralizing agent for the Carbopol 934.
Carbopol 934 is a water-soluble polyacrylic acid crosslinked with about 1% of polyallyl sucrose having an average of about 5.8 allyl groups for each sucrose molecule; US. Patent No. 3,133,865. Gantrez ES 335 I has the following repeating unit Which is a clear viscous liquid with an acid number of 255-285, a specific gravity of 0.957 and a density (pounds/gallon) of 7.98.
An example of the preparation and the method of mixing the same is as follows:
In forming the gel, the methyl and butyl parasepts are dissolved in isopropanol and the polyvinyl pyrrolidone K-30 is added under agitation. When completely dissolved, the Carbopol 934 is added slowly while subjecting the mixture to high speed agitation. The agitation should be continued until it is certain that no lumps remain. The mixture is then neutralized with Ethomeen C/25. This will form a thick gel. A second solution is made comprising 25% Lutonal M-40 and 75% isopropyl alcohol. This Lutanol/isopropyl alcohol mixture is then added to the thick gel under rapid agitation, which agitation is continued until a homogenous mixture has been formed. The resulting material will still be in gel form and can be packaged as desired for use.
The proportion of ingredients set forth above may be varied and still result in a gel usable for the purposes intended. The upper and lower limits of the ingredients are set forth below.
Ingredient Upper Limit Lower Limit lsopropanol 8071 50% Methyl and hutyl parasepts 57: 1% Lutonal M-40 50% 5% Polyvinyl pyrrolidone K-30 5% 1% Carbopol 934 5'7: 1%
upper limit and lower limit equalto percentage of Carbopol 934.
Ethomeen (/25 The isopropanol should, of course, be cosmetic grade.
in mixing the ingredients for the example set forth just above, the Klucel OP is added to the grams of isopropyl alcohol under high agitation. Continuing the agitation, the distilled water is added which will initially result in a granular appearing mixture, which will subsequently disappear during the mixing process.
The 10 grams of isopropanol is used to dissolve the sorbic acid and then the polyvinyl pyrrolidone is added thereto. The Gantrez ES 335 I is then mixed into the isopropanol/sorbic acid/polyvinyl pyrrolidone mixture and thoroughly mixed therein. The resulting mixture is then combined with the mixture first formed, and the two are thoroughly blended together. The result will be a gel of the desired viscosity and characteristics.
The upper and lower limits of the ingredients in Example 2 are set forth below.
plus what additional isopropanol CO is required to dissolve the polyvinyl pyrrolidone to form the second mixture described above.
As previously indicated, the gel formed in accordance with the formulation set forth may be applied without regard to the posture of the patient. The gel will dry to a thin coating surrounding the stoma and will not only improve the adhesion of the appliance. but also serves to protect the skin of the user from irritation.
1. A gelatinous mixture for application to human skin, comprising:
25 to by weight of isopropanol,
0.1 to 5% by weight of a preservative selected from the group consisting of sorbic acid, butyl parahydroxybenzoate and methyl parahydroxybenzoate,
O to 50% by weight of polyvinyl pyrrolidone,
5 to 50% by weight of a film forming agent selected from the group consisting of monoisopropyl ester of polyvinyl methylether and polyvinyl methylether, and
1.5 to 5% by weight of a gelling agent selected from the group consisting of hydroxypropyl cellulose and watersoluble polyacrylic acid crosslinked with 1% of polyallyl sucrose having an average of about 5.8 allyl groups for each sucrose molecule.
2. A gelatinous mixture for application to human skin, comprising:
25 to 90% by weight of isopropanol,
0.1 to 5% by weight of a preservative selected from the group consisting of sorbic acid, butyl parahydroxybenzoate and methyl parahydroxybenzoate.
0 to 5% by weight of polyvinyl pyrrolidone.
5 to 50% by weight of a film forming agent selected from the group consisting of monoisopropyl ester of polyvinyl methylether and polyvinyl methylether,
1.96 to 3% by weight of water-soluble polyacrylic acid crosslinked with l% of polyallyl sucrose having an average of about 5.8 allyl groups for each sucrose molecule.
2 to 3% by weight of polyoxyethylene cocoamine 5 having oxy groups.
3. A gelatinous mixture for application to human skin, comprising:
63 to 80% by weight of isopropanol,
0.l to 5% by weight of a preservative selected from the group consisting of butyl parahydroxybenzoate and methyl parahydroxybenzoate 1.0 to 5% by weight of polyvinyl pyrrolidone,
31 to 50% by weight of polyvinyl methylether,
2 to 3% by weight of water-soluble polyacrylic acid crosslinked with 1% of polyallyl sucrose having an average of about 5.8 allyl groups for each sucrose molecule, and
2.0 to 3% by weight of polyoxyethylene having 15 oxy groups cocoamine.
4. A gelatinous mixture for application to human skin, comprising:
5 to 45% by weight of monoisopropyl ester of polyvinyl methylether, and
2 to 10% by weight of hydroxypropyl cellulose.
5. A gelatinous mixture for application to human skin, comprising:
63% by weight of isopropanol,
less than 5% by weight of methyl parahydroxybenzoate and butyl para-hydroxybenzoate 1.0% by weight of polyvinyl pyrrolidone,
31% by weight of polyvinyl methylether,
2% by weight of water-soluble polyacrylic acid crosslinked with 1% of polyallyl sucrose having an average of about 5.8 allyl groups for each sucrose molecule, and
2% by weight of polyoxyethylene cocoamine having 15 oxy groups.
6. A gelatinous mixture for application to human skin, comprising:
% by weight of isopropylalcohol,
less than 0.4% by weight of sorbic acid,
1% by weight of polyvinyl pyrrolidone,
5% by weight of distilled water,
5% by weight of hydroxypropyl cellulose, and
9% by weight of monoisopropyl ester of polyvinyl methylether.
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION PATENT NO. 3,876,771 DATED 2 April 8, 1975 INVENTOR( 1 Wilhelm G. Denner it is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown beiow:
In the title, change "METHYLETHER MALEIC ACID" to METHYLETHER/MALEIC ACID The name of the assignee is HOLLIS'IER INCORPORATED.
Column 2, near the bottom of the table, the trade name "Gantrez ES 335" should read Gantrez ES 335 I.
Column 3, in the penultimate line of Example 2 "6771" should be deleted.
Signed and gealed this [SEAL] A ttes t:
C. MARSHALL DANN Commissioner of Parents and Trademarks RUTH C. MASON Arresting 0mm
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2542897 *||Oct 12, 1945||Feb 20, 1951||Harold A Abramson||Antiseptic wound dressings|
|US3134720 *||Jun 27, 1962||May 26, 1964||Bristol Myers Co||Medicated gels|
|US3269903 *||May 27, 1963||Aug 30, 1966||Bofors Ab||Liquid plastic dressing which absorbs ultraviolet light|
|US3485915 *||Apr 22, 1966||Dec 23, 1969||Revlon||Thickened hydroxypropyl cellulose compositions|
|US3632547 *||Jul 2, 1969||Jan 4, 1972||Synergistic Ind Inc||Textile adhesive and method of use|
|US3710779 *||Dec 14, 1971||Jan 16, 1973||Hoffmann La Roche||Method of ultrasonic coupling|
|US3749773 *||Feb 25, 1971||Jul 31, 1973||Warner Lambert Co||Gelled steroid ointment|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4140656 *||Oct 7, 1977||Feb 20, 1979||Armour-Dial, Inc.||Anhydrous clear gel facial cleanser|
|US4309414 *||Oct 23, 1979||Jan 5, 1982||Kowa Company Limited||Antiinflammatory analgesic gelled ointment|
|US4364929 *||Apr 30, 1980||Dec 21, 1982||The Purdue Frederick Company||Germicidal colloidal lubricating gels and method of producing the same|
|US4393080 *||Dec 24, 1981||Jul 12, 1983||E. R. Squibb & Sons, Inc.||Adhesive compositions|
|US4503034 *||Sep 2, 1983||Mar 5, 1985||Laboratoires Biotrol S.A||Paste for protecting the skin|
|US4680323 *||Dec 1, 1983||Jul 14, 1987||Hans Lowey||Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration|
|US5194261 *||May 4, 1992||Mar 16, 1993||Virgil Pichierri||Diaper rash treatment|
|US5320838 *||Dec 21, 1992||Jun 14, 1994||Pro Cure Products, Ltd.||Protectant for irritated skin containing polyethyleneglycols, polyvinylether salt anhydride and polyvinylpyrrolidone|
|US5618529 *||Oct 11, 1994||Apr 8, 1997||Pichierri; Virgil F.||Diaper rash treatment|
|US6123958 *||Dec 9, 1997||Sep 26, 2000||Johnson & Johnson Medical, Inc.||Web dressing and method for its production|
|US6312415||May 25, 1998||Nov 6, 2001||Coloplast A/S||Ostomy appliance|
|US6332879||May 25, 1998||Dec 25, 2001||Coloplast A/S||Ostomy appliance|
|US7837984||Dec 27, 2002||Nov 23, 2010||Avon Products, Inc.||Post-foaming cosmetic composition and method employing same|
|US7837985||Dec 19, 2003||Nov 23, 2010||Avon Products, Inc||Post application expanding cosmetic composition and method employing same|
|US7846424||Dec 19, 2003||Dec 7, 2010||Avon Products, Inc||Non-pressurized post-application expanding composition|
|US20030223950 *||Apr 25, 2003||Dec 4, 2003||Michael Lede||Water-free hairstyling gels|
|US20040054015 *||Aug 19, 2003||Mar 18, 2004||Thomsen John Brown||Gel for treatment of skin diseases|
|US20040126345 *||Dec 27, 2002||Jul 1, 2004||Mcnamara William E.||Post-foaming cosmetic composition and method employing same|
|US20050175563 *||Dec 19, 2003||Aug 11, 2005||Mcnamara William E.||Post application expanding cosmetic composition and method employing same|
|US20060088486 *||Dec 19, 2003||Apr 27, 2006||Mcnamara William E||Topical use of post-application expanding cosmetic composition|
|US20060147399 *||Dec 19, 2003||Jul 6, 2006||Mcnamara William E||Non-pressurized post-application expanding composition|
|EP0048556A1 *||Aug 27, 1981||Mar 31, 1982||E.R. Squibb & Sons, Inc.||Hydrocolloid containing paste-like composition|
|WO1992009289A1 *||Nov 27, 1991||Jun 11, 1992||Biolab Pharmaceuticals, Inc.||Diaper rash treatment|
|U.S. Classification||424/78.5, 424/78.2, 514/781, 424/78.6|
|International Classification||A61K31/765, A61L15/00, A61L24/04, B65G47/54, A61K31/79, A61F5/443, A61K9/70, A61L26/00, A61K9/00, A61L27/00|
|Cooperative Classification||A61L24/043, A61L2400/14|